Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DermTech, Inc.CNACU · Entity 89998 | Director · CEO & Chairman · 10% owner | June 23, 2017 | June 26, 2017 |
| Humacyte, Inc.HUMA · Entity 6478 | Director | June 15, 2023 | June 16, 2023 |
| Longevity Health Holdings, Inc.CTCX · Entity 8659 | Director · Chairman and CEO · 10% owner | October 11, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DermTech, Inc.
Report date June 23, 2017 · Filed June 26, 2017
Jointly reported with Centripetal, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 3,882,500 |
Last balance in matching sequence
After 2017-06-23 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2017-06-23 · Purchase · Acquired 425,000 · Balance 4,018,750 F1: These shares are underlying units (each unit consisting of one ordinary share, one right entitling the holder thereof to receive one-tenth (1/10) of one share upon the consummation of an initial business combination and one warrant to purchase one-half of one share) held by Centripetal LLC (the "Sponsor"), acquired pursuant to a second amended and restated unit subscription agreement by and between the Sponsor and the issuer. F2: The shares held by the Sponsor are beneficially owned by Rajiv Shukla, the issuer's Chairman and Chief Executive Officer and the managing member of the Sponsor, who has sole voting and dispositive power over the shares held by the Sponsor. F3: Mr. Shukla disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest. Row 2 · 2017-06-23 · Other · Disposed 136,250 · Balance 3,882,500 F4: As contemplated in connection with the initial public offering of the issuer, 136,250 ordinary shares of the issuer were forfeited by the Sponsor and returned to the issuer for no consideration as a result of the issuance of 136,250 ordinary shares by the issuer to Cowen Investments, LLC upon consummation of the sale of private units in connection with the issuer's initial public offering. F2: The shares held by the Sponsor are beneficially owned by Rajiv Shukla, the issuer's Chairman and Chief Executive Officer and the managing member of the Sponsor, who has sole voting and dispositive power over the shares held by the Sponsor. F3: Mr. Shukla disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are underlying units (each unit consisting of one ordinary share, one right entitling the holder thereof to receive one-tenth (1/10) of one share upon the consummation of an initial business combination and one warrant to purchase one-half of one share) held by Centripetal LLC (the "Sponsor"), acquired pursuant to a second amended and restated unit subscription agreement by and between the Sponsor and the issuer.
F2: The shares held by the Sponsor are beneficially owned by Rajiv Shukla, the issuer's Chairman and Chief Executive Officer and the managing member of the Sponsor, who has sole voting and dispositive power over the shares held by the Sponsor.
F3: Mr. Shukla disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest.
F4: As contemplated in connection with the initial public offering of the issuer, 136,250 ordinary shares of the issuer were forfeited by the Sponsor and returned to the issuer for no consideration as a result of the issuance of 136,250 ordinary shares by the issuer to Cowen Investments, LLC upon consummation of the sale of private units in connection with the issuer's initial public offering.
Humacyte, Inc.
Report date June 15, 2023 · Filed June 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.35 · Expires 2033-06-15 | Direct | 8,500 |
Reported balance
After 2023-06-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-15 · Grant · Acquired 8,500 · Balance 8,500 F1: The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027.
Longevity Health Holdings, Inc.
Report date October 11, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-10-11 | Direct | 876,878 |
Reported balance
After 2024-10-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-10-11 · Grant · Acquired 876,878 · Balance 876,878 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.88 · Expires 2033-10-09 | Direct | 426,878 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 426,878 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2034-07-26 | Direct | 450,000 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 450,000 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Common StockSEC Table I · non-derivative | Direct | 3,328,653 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,328,653 |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2024 Filed Nov 8, 2024 17:00 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 876,878 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-124215 · ownership.xml · derivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 876,878 Underlying: Common Stock · 876,878 shares Expires 2034-10-11 F1 · derivative.exercise_date: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| July 26, 2024 Filed Aug 8, 2024 17:39 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 450,000 | $1.00 Strike: $1.00 | $450,000.00 |
DisclosureSEC source: 0000950170-24-094223 · ownership.xml · derivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 876,878 Underlying: Common Stock · 450,000 shares Expires 2034-07-26 F2 · derivative.exercise_date: Options to purchase 450,000 shares of common stock of Carmell Corporation were granted on July 26, 2024 and vest as follows: 25% vested on July 26, 2025 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date. F3 · balance_after: Includes options to purchase 426,878 shares of common stock of Carmell Corporation that were granted on October 9, 2023 and vest as follows: 25% vest on October 9, 2024 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 09:03 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,100 | $2.63 | $5,526.57 |
DisclosureSEC source: 0000950170-24-071092 · ownership.xml · nonDerivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,103 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.58 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| May 30, 2024 Filed Jun 10, 2024 09:03 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,000 | $2.50 | $5,000.00 |
DisclosureSEC source: 0000950170-24-071092 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,003 Read SEC document |
| May 28, 2024 Filed Jun 10, 2024 09:03 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 20 | $2.57 | $51.40 |
DisclosureSEC source: 0000950170-24-071092 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,003 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.50 to $2.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 24, 2024 Filed May 28, 2024 17:02 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,939 | $2.57 | $4,990.99 |
DisclosureSEC source: 0000950170-24-065344 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,983 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.50 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 23, 2024 Filed May 28, 2024 17:02 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,100 | $2.50 | $5,250.00 |
DisclosureSEC source: 0000950170-24-065344 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,044 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 22, 2024 Filed May 22, 2024 17:13 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 4,051 | $2.41 | $9,771.01 |
DisclosureSEC source: 0000950170-24-063592 · ownership.xml · nonDerivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,944 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.35 to $2.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 21, 2024 Filed May 22, 2024 17:13 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,515 | $2.39 | $3,616.31 |
DisclosureSEC source: 0000950170-24-063592 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,893 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.33 to $2.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 20, 2024 Filed May 22, 2024 17:13 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,172 | $2.22 | $2,600.67 |
DisclosureSEC source: 0000950170-24-063592 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,378 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.18 to $2.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 04, 2024 Filed May 22, 2024 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 8,680 | $2.88 | $24,998.40 |
DisclosureSEC source: 0000950170-24-063586 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,206 Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:55 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 502 | $2.50 | $1,255.00 |
DisclosureSEC source: 0000950170-23-067903 · ownership.xml · nonDerivative · entry 4 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,179 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:55 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 5,600 | $2.66 | $14,916.72 |
DisclosureSEC source: 0000950170-23-067903 · ownership.xml · nonDerivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,677 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.51 to $2.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3. Read SEC document |
| November 29, 2023 Filed Dec 4, 2023 21:55 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 5,014 | $2.91 | $14,578.21 |
DisclosureSEC source: 0000950170-23-067903 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,077 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.83 to $2.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 Read SEC document |
| November 28, 2023 Filed Dec 4, 2023 21:55 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,501 | $2.92 | $7,303.17 |
DisclosureSEC source: 0000950170-23-067903 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,063 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.86 to $2.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| November 27, 2023 Filed Nov 28, 2023 18:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,100 | $2.97 | $6,247.29 |
DisclosureSEC source: 0000950170-23-066517 · ownership.xml · nonDerivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,562 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.91 to $3.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| November 24, 2023 Filed Nov 28, 2023 18:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,715 | $2.95 | $7,998.93 |
DisclosureSEC source: 0000950170-23-066517 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,462 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.80 to $3.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2. Read SEC document |
| November 22, 2023 Filed Nov 28, 2023 18:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,185 | $2.78 | $3,290.98 |
DisclosureSEC source: 0000950170-23-066517 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,747 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| November 21, 2023 Filed Nov 21, 2023 21:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 200 | $2.49 | $497.14 |
DisclosureSEC source: 0000950170-23-065682 · ownership.xml · nonDerivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,562 Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 3,750 | $2.62 | $9,817.13 |
DisclosureSEC source: 0000950170-23-065682 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,362 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.30 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,000 | $2.69 | $5,379.80 |
DisclosureSEC source: 0000950170-23-065682 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,612 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| August 28, 2023 Filed Aug 31, 2023 16:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 2,100 | $3.50 | $7,343.07 |
DisclosureSEC source: 0001213900-23-072813 · ownership.xml · nonDerivative · entry 7 Shukla Rajiv · CIK 0001709033 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,612 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.43 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3. Read SEC document |
| August 25, 2023 Filed Aug 31, 2023 16:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 600 | $3.50 | $2,100.00 |
DisclosureSEC source: 0001213900-23-072813 · ownership.xml · nonDerivative · entry 6 Shukla Rajiv · CIK 0001709033 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,512 Read SEC document |
| August 24, 2023 Filed Aug 31, 2023 16:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 500 | $3.50 | $1,750.00 |
DisclosureSEC source: 0001213900-23-072813 · ownership.xml · nonDerivative · entry 5 Shukla Rajiv · CIK 0001709033 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,912 Read SEC document |
| August 21, 2023 Filed Aug 31, 2023 16:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 100 | $3.54 | $354.00 |
DisclosureSEC source: 0001213900-23-072813 · ownership.xml · nonDerivative · entry 4 Shukla Rajiv · CIK 0001709033 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,412 Read SEC document |
| August 18, 2023 Filed Aug 31, 2023 16:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 4,100 | $3.62 | $14,825.19 |
DisclosureSEC source: 0001213900-23-072813 · ownership.xml · nonDerivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,312 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.57 to $3.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2. Read SEC document |
| August 17, 2023 Filed Aug 31, 2023 16:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 100 | $3.54 | $354.00 |
DisclosureSEC source: 0001213900-23-072813 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,212 Read SEC document |
| August 16, 2023 Filed Aug 31, 2023 16:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,112 | $3.74 | $4,153.76 |
DisclosureSEC source: 0001213900-23-072813 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,112 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:10 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 8,500 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001818382-23-000087 · wf-form4_168694621566524.xml · derivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2033-06-15 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027. Read SEC document |
| January 02, 2023 Filed Jan 4, 2024 21:17 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantCommon Stock | 14,347 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-002269 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,526 F1 · price: The indicated shares were issued to the Reporting Person pursuant to the Executive Employment Agreement between the Issuer and the Reporting Person dated December 29, 2023. Such agreement was included in the Issuer's Form 8-K filed on January 5, 2024. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:22 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 8,500 | $0.00 Strike: $4.34 | $0.00 |
DisclosureSEC source: 0001818382-22-000094 · wf-form4_165515175246689.xml · derivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-09 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 19:34 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 13,000 | $0.00 Strike: $10.03 | $0.00 |
DisclosureSEC source: 0001104659-21-126706 · tm2130120-9_4seq1.xml · derivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2031-10-13 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025. Read SEC document |
| July 26, 2021 Filed Nov 21, 2023 21:01 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-065682 · ownership.xml · nonDerivative · entry 4 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F3 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F3 · ownership.nature: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| July 26, 2021 Filed Nov 28, 2023 18:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-066517 · ownership.xml · nonDerivative · entry 4 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F4 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F4 · balance_after: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F4 · ownership.nature: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| July 26, 2021 Filed Dec 4, 2023 21:55 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-067903 · ownership.xml · nonDerivative · entry 5 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F4 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F4 · ownership.direct: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F4 · ownership.nature: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| July 26, 2021 Filed Jan 4, 2024 21:17 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-002269 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F2 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F2 · ownership.nature: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| July 26, 2021 Filed May 22, 2024 17:13 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-063592 · ownership.xml · nonDerivative · entry 4 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F4 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F4 · balance_after: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F4 · ownership.direct: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| July 26, 2021 Filed May 22, 2024 17:10 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-063586 · ownership.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F1 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F1 · balance_after: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F1 · ownership.direct: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| July 26, 2021 Filed May 28, 2024 17:02 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065344 · ownership.xml · nonDerivative · entry 3 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F3 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F3 · balance_after: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F3 · ownership.direct: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| July 26, 2021 Filed Jun 10, 2024 09:03 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071092 · ownership.xml · nonDerivative · entry 4 Shukla Rajiv · CIK 0001709033 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By AHAC Sponsor III LLC Disclosed balance after: 4,249,908 F3 · kind: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F3 · balance_after: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. F3 · ownership.direct: AHAC Sponsor III LLC (the "Sponsor") is the record holder of these shares and reported the ownership of these shares on Form 3 filed with the SEC on July 26, 2021. The Reporting Person is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. The Reporting Person filed a Form 3 related to its indirect beneficial ownership of these shares on July 26, 2021. The Reporting Person disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| September 22, 2020 Filed Sep 23, 2020 20:30 UTC | Humacyte, Inc. AHACU · Entity 6478 | OtherClass A Common Stock | 305,000 | $10.00 | $3,050,000.00 |
DisclosureSEC source: 0001213900-20-028048 · ownership.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · Chief Executive Officer · 10% owner AHAC Sponsor LLC · CIK 0001818390 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 305,000 F1 · kind: Consists of 305,000 placement units purchased by AHAC Sponsor LLC ("Sponsor") for $10.00 per unit in a private placement transaction with the registrant. Each such unit consists of one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment. F2 · ownership.nature: Sponsor is the record holder of the securities reported herein. Mr. Rajiv Shukla is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Shukla disclaims beneficial ownership over any securities in which he does not have a pecuniary interest. Read SEC document |
| June 23, 2017 Filed Jun 26, 2017 19:18 UTC | DermTech, Inc. CNACU · Entity 89998 | OtherOrdinary Shares | 136,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-034149 · v469736_4.xml · nonDerivative · entry 2 Shukla Rajiv · CIK 0001709033 · Director · CEO & Chairman · 10% owner Centripetal, LLC · CIK 0001709121 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,882,500 F4 · shares: As contemplated in connection with the initial public offering of the issuer, 136,250 ordinary shares of the issuer were forfeited by the Sponsor and returned to the issuer for no consideration as a result of the issuance of 136,250 ordinary shares by the issuer to Cowen Investments, LLC upon consummation of the sale of private units in connection with the issuer's initial public offering. F2 · ownership.direct: The shares held by the Sponsor are beneficially owned by Rajiv Shukla, the issuer's Chairman and Chief Executive Officer and the managing member of the Sponsor, who has sole voting and dispositive power over the shares held by the Sponsor. F3 · ownership.direct: Mr. Shukla disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest. Read SEC document |
| June 23, 2017 Filed Jun 26, 2017 19:18 UTC | DermTech, Inc. CNACU · Entity 89998 | PurchaseOrdinary Shares | 425,000 | $10.00 | $4,250,000.00 |
DisclosureSEC source: 0001144204-17-034149 · v469736_4.xml · nonDerivative · entry 1 Shukla Rajiv · CIK 0001709033 · Director · CEO & Chairman · 10% owner Centripetal, LLC · CIK 0001709121 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,018,750 F1 · shares: These shares are underlying units (each unit consisting of one ordinary share, one right entitling the holder thereof to receive one-tenth (1/10) of one share upon the consummation of an initial business combination and one warrant to purchase one-half of one share) held by Centripetal LLC (the "Sponsor"), acquired pursuant to a second amended and restated unit subscription agreement by and between the Sponsor and the issuer. F2 · ownership.direct: The shares held by the Sponsor are beneficially owned by Rajiv Shukla, the issuer's Chairman and Chief Executive Officer and the managing member of the Sponsor, who has sole voting and dispositive power over the shares held by the Sponsor. F3 · ownership.direct: Mr. Shukla disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.